#USA #New York #Class Action #Pomerantz Law #Doximity Inc

Important Investor Alert: Class Action Lawsuit Against Doximity, Inc.

Pomerantz LLP, a distinguished law firm renowned for its expertise in corporate securities litigation, has issued a reminder to investors regarding an active class action lawsuit against Doximity, Inc. (NYSE: DOCS). Those who have incurred losses due to their investment in the company are encouraged to take action and join the lawsuit before the approaching deadline.

Overview of the Class Action Suit

The lawsuit aims to address potential wrongdoing by Doximity and some of its executives and board members regarding securities fraud and wrongful business practices. If you have purchased or acquired Doximity securities during the designated class period, you may be eligible to become a lead plaintiff. Interested parties are encouraged to reach out to Danielle Peyton at Pomerantz via email or phone to express their intent to participate.

The timeline for interested investors is critical, with November 16, 2026, set as the deadline for class member participation. Investors failing to take action by this date may miss their opportunity to join the class, potentially impacting their ability to seek redress for their losses.

Timeline of Events Affecting Doximity's Stock

A troubling pattern led to the filing of this lawsuit, marked by significant fluctuations in Doximity’s stock price over a relatively short period:

• - November 6, 2025: Doximity reported solid second-quarter results but raised concerns over advertising revenue, hinting at a slowdown in sales for the latter half of the fiscal year. Following this announcement, the stock plummeted by $8.29, closing at $54.29.

• - February 5, 2026: The company slashed its revenue projections for the entire fiscal year and acknowledged slower sales growth along with a decline in net income, leading to a further stock decline of $5.59, resulting in a share price of $27.73 by February 6.

• - May 13, 2026: Doximity revealed it had missed its reduced revenue targets, forecasting even slower growth for the upcoming fiscal year. Consequently, the stock experienced a dramatic drop of $5.38, closing at $18.01 on May 14, representing a 23% decline.

These developments have sparked concern among investors regarding the company's operational integrity, prompting legal intervention by Pomerantz LLP.

Pomerantz Law Firm's Commitment

Pomerantz LLP has a storied history of advocating for investors’ rights, having been established over 85 years ago by legal pioneer Abraham L. Pomerantz, often regarded as the father of the class action. Over the years, the firm has been instrumental in recovering substantial damages for victims of corporate misconduct and securities fraud.

As a participant in this class action, investors stand to benefit from collective efforts to hold Doximity accountable. Potential recoveries could provide essential financial redress for those impacted by the company's alleged malpractices.

How to Take Action

Interested investors should reach out quickly, providing details such as their address, phone number, and the number of shares bought. Doing so will enable them to stay informed and fully participate in the proceedings. For additional information and copies of the complaint, individuals can visit Pomerantz LLP's website at www.pomerantzlaw.com.

In conclusion, if you or someone you know has invested in Doximity, it is crucial to remain vigilant and proactive in this matter. With deadlines approaching, ignorance could mean lost opportunities for recovery. Make sure to contact Pomerantz LLP to learn more about your rights and options as an investor.